Zelira Therapeutics Limited (ZLDAF)
OTCMKTS · Delayed Price · Currency is USD
0.2223
-0.0203 (-8.37%)
At close: Oct 21, 2025
Zelira Therapeutics Market Cap
Zelira Therapeutics has a market cap or net worth of $2.71 million as of October 27, 2025. Its market cap has decreased by -53.07% in one year.
Market Cap
2.71M
Enterprise Value
4.21M
Revenue
430.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 11.37M to 2.71M, a decrease of -76.17%. That is a compound annual growth rate of -14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 2.73M | -37.31% |
| Dec 31, 2024 | 4.35M | -37.46% |
| Dec 29, 2023 | 6.96M | 6.95% |
| Dec 30, 2022 | 6.51M | -78.83% |
| Dec 31, 2021 | 30.74M | -63.46% |
| Dec 31, 2020 | 84.13M | 186.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |